PL1499278T3 - Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon - Google Patents

Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon

Info

Publication number
PL1499278T3
PL1499278T3 PL04737220T PL04737220T PL1499278T3 PL 1499278 T3 PL1499278 T3 PL 1499278T3 PL 04737220 T PL04737220 T PL 04737220T PL 04737220 T PL04737220 T PL 04737220T PL 1499278 T3 PL1499278 T3 PL 1499278T3
Authority
PL
Poland
Prior art keywords
dosage form
immediate
pharmaceutical dosage
release pharmaceutical
polymorphous tibolone
Prior art date
Application number
PL04737220T
Other languages
English (en)
Inventor
Haan Pieter N V Organon De
Original Assignee
Msd Oss Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33442854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1499278(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Msd Oss Bv filed Critical Msd Oss Bv
Publication of PL1499278T3 publication Critical patent/PL1499278T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL04737220T 2003-05-23 2004-05-19 Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon PL1499278T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03101500 2003-05-23
EP04737220A EP1499278B1 (en) 2003-05-23 2004-05-19 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
PCT/EP2004/050852 WO2004103378A1 (en) 2003-05-23 2004-05-19 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Publications (1)

Publication Number Publication Date
PL1499278T3 true PL1499278T3 (pl) 2005-09-30

Family

ID=33442854

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04737220T PL1499278T3 (pl) 2003-05-23 2004-05-19 Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon

Country Status (16)

Country Link
US (1) US20060134191A1 (pl)
EP (1) EP1499278B1 (pl)
JP (1) JP2006514996A (pl)
KR (2) KR20050038590A (pl)
AT (1) ATE296606T1 (pl)
AU (1) AU2004203420B8 (pl)
CA (1) CA2473718A1 (pl)
DE (1) DE602004000016T2 (pl)
DK (1) DK1499278T3 (pl)
ES (1) ES2243919T3 (pl)
MX (1) MXPA05000824A (pl)
NZ (1) NZ534446A (pl)
PL (1) PL1499278T3 (pl)
PT (1) PT1499278E (pl)
WO (1) WO2004103378A1 (pl)
ZA (1) ZA200406042B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274386T3 (es) * 2004-02-06 2007-05-16 Helm Ag Preparaciones farmaceuticas que contienen tibolona amorfa.
RU2517140C2 (ru) * 2007-10-25 2014-05-27 Новартис Аг Способ обработки упаковки с однократной дозой лекартвенного препарата
KR101361244B1 (ko) * 2012-02-23 2014-02-11 박현석 무선 메시지를 이용한 문서 전송 시스템 및 방법
CN107078529A (zh) * 2015-11-02 2017-08-18 约瑟夫·古德里奇 可充电式照明鞋子

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (pl) * 1964-06-16
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
EP1251855A1 (en) * 2000-01-28 2002-10-30 Endorecherche, Inc. Selective estrogen receptor modulators in combination with estrogens
ATE364619T1 (de) * 2001-10-18 2007-07-15 Norton Healthcare Ltd Tibolonformulierungen

Also Published As

Publication number Publication date
JP2006514996A (ja) 2006-05-18
NZ534446A (en) 2007-03-30
ZA200406042B (en) 2006-05-31
WO2004103378A1 (en) 2004-12-02
DE602004000016D1 (de) 2005-07-07
AU2004203420B2 (en) 2008-01-31
EP1499278B1 (en) 2005-06-01
ES2243919T3 (es) 2005-12-01
CA2473718A1 (en) 2004-11-23
PT1499278E (pt) 2005-08-31
DK1499278T3 (da) 2005-10-03
DE602004000016T2 (de) 2005-11-03
EP1499278A1 (en) 2005-01-26
ATE296606T1 (de) 2005-06-15
US20060134191A1 (en) 2006-06-22
KR20060028822A (ko) 2006-04-03
MXPA05000824A (es) 2005-04-28
KR20050038590A (ko) 2005-04-27
AU2004203420A1 (en) 2004-12-02
AU2004203420B8 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
GEP20074047B (en) Pramipexole once-daily dosage form
DK0954314T3 (da) Doseringsformer til bedring af mandlig erektionsdefekt
MY129356A (en) Electrospun pharmaceutical compositions
WO2005041968A3 (en) Once-a-day, oral, controlled-release, oxycodone dosage forms
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
BG108516A (en) Pharmaceutical formulation
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
IL165786A0 (en) Ibuprofen suspension
IL150528A0 (en) Ibuprofen containing active agent preparation
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
BR0112847A (pt) Uso de uma forma de dosagem sólida
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
GB0001315D0 (en) Organic compounds
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
MY141008A (en) Oral formulations of deoxypeganine and their uses
DE60211916D1 (de) Synergistische füllzusammensetzung
WO2007119249A3 (en) Pharmaceutical compositions of cefixime
TW200621304A (en) Pharmaceutical composition
TW200621224A (en) Pharmaceutical composition
WO2005115092A3 (en) Micronized oral pharmaceutical composition
IL162769A0 (en) Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen
ECSP982396A (es) Composiciones que contienen tetrahidrolipstatina